Safety, Tolerability and Immunogenicity of V114 in Healthy Adults and Infants (V114-004)

Clinical trial NCT02037984 · COMPLETED

Trial details

NCT number: NCT02037984
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Streptococcus Pneumoniae Infection Pneumococcal Infections

Start date: 2014-01-28
Primary completion: 2016-07-01
Enrollment: 341

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.